Template for information from HF to patients (PDF)
Introduction of other surgical and invasive methods (PDF)
Letter from NGICG-CR to the regional medical directors (PDF)
Process chart – New methods (PDF)
Questions from NHIB to the seven relevant hospitals
Below are the questions NHIB sent to the relevant hospitals.
|1. Introduction of taTME||What was the decision-making process on the introduction of taTME? When was the first patient operated using taTME?
When was the last patient operated using taTME? What was the reason that you suspended use of this procedure?
How was the training and guidance of surgeons in the taTME method arranged?
Was there a proctor scheme at the hospital in connection with implementation of the method? How was this carried out?
|3. Clinical trial||
Were the patients who underwent taTME surgery included in a clinical trial? Attach documentation/protocol
Was any data sent to foreign trials? Attach documentation/protocol
Was the trial registered in REK? Was it also registered anywhere else? Attach documentation
Was the trial reported to the data protection officer (DPO)? Attach documentation
|4. Information for patients||
Did the patients who underwent surgery using the taTME method receive information that this is a technique in a developmental phase? Attach documentation
Did the patients receive an information letter and/or consent form about this? Attach documentation
Were the patients who underwent surgery using taTMe at your hospital subsequently informed that the method had been suspended due to complications and oncological results? Attach documentation
Did patients have a choice between surgery using taTME or the traditional method?
Was it registered in the medical records that the patients were informed that they were to be operated on using a new technique that is subject to development?
|5. Quality improvement||
Did the hospital perform an internal review/internal scrutiny of the introduction of the taTME method after it was suspended? Attach documentation
If the patients you operated on were among those who suffered a recurrence or complications after the taTNME surgery – was notification of this sent to the supervisory authorities?